SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001999371-24-002942
Filing Date
2024-02-29
Accepted
2024-02-29 16:25:23
Documents
2
Group Members
22NW FUND GP, LLC22NW GP, INC.22NW, LPARON R. ENGLISHBRYSON O. HIRAI-HADLEYNATHANIEL CALLOWAY

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP lifecore_sc13da-011124.htm SC 13D/A 238044
2 JOINT FILING AGREEMENT ex99-1.htm EX-99.1 14170
  Complete submission text file 0001999371-24-002942.txt   254043
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Subject) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: SC 13D/A | Act: 34 | File No.: 005-45181 | Film No.: 24704106
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107
Business Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107 206-227-3078
22NW Fund, LP (Filed by) CIK: 0001640809 (see all company filings)

IRS No.: 473303449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A